HCWB
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- HCW Biologics continues progress toward completing an IND application for a clinical trial of its lead T-cell engager in solid tumorsOct 12, 2026
- HCW Biologics strengthened its U.S. patent portfolio for HCW9302, its lead clinical-stage immunotherapy for alopecia areataSep 7, 2026
- HCW Biologics reported positive preliminary human data from its Phase 1 trial of HCW9302 in alopecia areataJun 16, 2026
- HCW Biologics provided a major update on its T-cell engager program, validating tissue factor as a target for solid tumorsApr 27, 2026
- HCW Biologics designates one of its proprietary TRBC-Pembrolizumab-based immune checkpoint inhibitors as its franchise immunotherapeutic for internal clinical developmentSep 16, 2025